A quick analogy that helps clients stay grounded
In 2025, ongoing trials are evaluating whether MEK inhibition can delay or prevent malignant transformation, or serve as a neoadjuvant strategy to shrink MPNST prior to surgery (Gross et al., 2024)
Coverage Rules, Denials, and Appeal Options Medicare Advantage plans do not cover Zepbound (tirzepatide) for weight loss under current CMS rules
Melanotan 1 safety remains an area for further research
If you dont have insurance and are paying with cash, you can also get Wegovy for $199-$349 per month through Ro , thanks to its integration with NovoCare, the manufacturers online pharmacy
It can also lower A1C levels and help with weight loss